27951-88-8

Upstream product

• 67083-24-3 2-(diethylamino)-N-(2,6-dimethyl-4-nitrophenyl)acetamide 
• 16947-63-0 2,6-dimethyl-4-nitroaniline 
• 137-58-6 2-diethylamino-N-(2,6-dimethylphenyl)-acetamide 
• 67083-23-2 2-chloro-N-(2,6-dimethyl-4-nitrophenyl)acetamide 

Downstream Products

• 98017-21-1 4-Diethylamino-acetamido-3,5-dimethylphenyl-carbaminsaeure-2-isohexylester 
• 93737-03-2 4-Diethylamino-acetamido-3,5-dimethyl-phenyl-carbaminsaeure-ethylester 
• 95706-26-6 4-Diethylamino-acetamido-3,5-dimethylphenyl-carbaminsaeure-isoamylester 
• 97016-35-8 4-Diethylamino-acetamido-3,5-dimethyl-phenyl-carbaminsaeure-(1-ethyl)-butylester 
• 97016-36-9 4-Diethylamino-acetamido-3,5-dimethylphenyl-carbaminsaeure-2-ethyl-butylester 
• 96378-17-5 1',3'-Bis-(4-diethylamino-acetamido-3,5-dimethyl-phenyl)-harnstoff 
• 95706-82-4 1-(4'-Diethylamino-acetamido-3',5'-dimethylphenyl)-3-pentyl-harnstoff 
• 94966-92-4 N-(4-Diethylamino-acetamido-3,5-dimethylphenyl)-N'-phenyl-harnstoff 
• 94435-16-2 1-(4'-Diethylaminoacetamido-3',5'-dimethylphenyl)-3-butyl-harnstoff 
• 83473-43-2 2-Diethylamino-N-[2,6-dimethyl-4-(toluene-4-sulfonylamino)-phenyl]-acetamide 
• 83473-84-1 N,N-diethyl-glycine-(4-butylamino-2,6-dimethyl-anilide) 
• 83473-57-8 N-{4-[Butyl-(toluene-4-sulfonyl)-amino]-2,6-dimethyl-phenyl}-2-diethylamino-acetamide 
• 95564-65-1 4-Diethylamino-acetamido-3,5-dimethyl-phenyl-carbamidsaeure-octylester 
• 95808-30-3 4-Diethylamino-acetamido-3,5-dimethylphenyl-carbamidsaeure-heptylester 

Relevant academic research and scientific papers

C-H Amination of Arenes with Hydroxylamine

This Letter describes the development of a TiIII-mediated reaction for the C-H amination of arenes with hydroxylamine. This reaction is applied to a variety of electron-rich (hetero)arene substrates, including a series of natural products and pharmaceuticals. It offers the advantages of mild conditions (room temperature), fast reaction rates (30 min), compatibility with ambient moisture and air, scalability, and the use of inexpensive commercial reagents.

Lidocaine antigens and antibodies

Derivatives of anesthetics involving anilides, lidocaine being illustrative, are provided, having an annular amino group. A difunctional linking group is provided, which provides a link to the annular amino group and an antigen, with the resulting conjugate being employed for the preparation of antibodies. The antibodies find particular use in competitive protein binding assays. Conjugates to enzymes are prepared which find particular use in homogeneous enzyme immunoassays.